The research report includes specific segments by region (country), by company, by Purity and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Purity Above 97 % Above 98 % Above 99 % Segment by Application Tablets Capsules Pellet and Granule Suppository Enema Others By Region North America U.S. Canada Europe Germany France U.K. Italy Russia Asia-Pacific China Japan South Korea India Australia Taiwan Indonesia Thailand Malaysia Philippines Vietnam Latin America Mexico Brazil Argentina Middle East & Africa Turkey Saudi Arabia UAE By Company PharmaZell Syntese A/S Cambrex Corporation Divis Laboratories Chemi SpA Ipca Laboratories Hangzhou Brother Lianyungang Fengheng Biopharm Lasa Loboratory Corden Pharma Bergamo Erregierre SpA CTX Lifescience Ishita Active Pharma Ingredients YC Biotech (Jiangsu) Xinxiang Tianfeng Fine Chemical
1 Mesalazine Market Overview 1.1 Product Overview and Scope of Mesalazine 1.2 Mesalazine Segment by Purity 1.2.1 Global Mesalazine Sales Growth Rate Comparison by Purity (2022-2028) 1.2.2 Above 97 % 1.2.3 Above 98 % 1.2.4 Above 99 % 1.3 Mesalazine Segment by Application 1.3.1 Global Mesalazine Sales Comparison by Application: (2022-2028)